BPC-157 (Pentadecapeptide)

BPC-157 and Blood Vessels

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Vascular effects are among the most consistently reported findings, with Seiwerth and colleagues reviewing BPC-157 and blood vessels in Current Pharmaceutical Design in 2014. Angiogenesis is the most plausible common thread linking reported activity across otherwise unrelated tissues.

Key facts

Key review
Seiwerth, Curr Pharm Des 2014 (PMID 23782145)
Reported involvement
VEGF-related signalling
Model systems
Predominantly rat
Why it matters
Repair in most tissues requires vasculature
Receptor
None identified
Human data
Limited

Why angiogenesis could be the unifying thread

BPC-157 is reported active in gut, tendon, ligament, muscle and eye. Those tissues have little in common except that repair in all of them requires blood supply. If a compound affects vessel formation, effects across unrelated tissues become less surprising: one mechanism producing many apparent activities rather than many separate mechanisms.

What the literature reports

Seiwerth and colleagues reviewed the vascular findings in 2014. Reported involvement includes VEGF-related signalling, which is the principal pathway driving new vessel formation. Effects on vessel behaviour in injury models recur across the Zagreb group's output in different tissue systems.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

The mechanistic gap that remains

Reporting that a compound affects angiogenesis is not the same as explaining how. Without an identified receptor there is no molecular starting point, so the angiogenic finding is itself a description rather than a mechanism. It moves the question from why does this work in five tissues to how does it affect vessels, which is progress but not resolution.

The caution angiogenesis always warrants

Promoting vessel growth is not uniformly beneficial. Angiogenesis is central to tumour growth as well as to tissue repair, which is why the therapeutic angiogenesis field has proceeded carefully. A compound reported to promote it deserves that same care in description, and this library reports findings rather than characterising them as benefits.

Where the evidence sits

Predominantly rat models from one research group. The currently recruiting Phase 2 trial in hamstring muscle strain is relevant here. Muscle repair depends on vascular supply, so a positive result would be consistent with the angiogenic hypothesis, though a clinical endpoint does not identify a mechanism.

Frequently asked questions

Does BPC-157 promote angiogenesis?

Vascular effects are consistently reported in preclinical models, with VEGF-related signalling implicated. The mechanism behind it is not established.

Why would that explain effects in different tissues?

Repair in most tissues depends on blood supply, so one vascular mechanism could produce apparent activity across unrelated systems.

Is promoting angiogenesis desirable?

Not uniformly. It underlies tumour growth as well as tissue repair, which is why the field describes it carefully.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More BPC-157 (Pentadecapeptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.